186 related articles for article (PubMed ID: 35406574)
1. Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors.
Principi E; Sondo E; Bianchi G; Ravera S; Morini M; Tomati V; Pastorino C; Zara F; Bruno C; Eva A; Pedemonte N; Raffaghello L
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406574
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer.
Bromberg KD; Kluger HM; Delaunay A; Abbas S; DiVito KA; Krajewski S; Ronai Z
Cancer Res; 2007 Sep; 67(17):8172-9. PubMed ID: 17804730
[TBL] [Abstract][Full Text] [Related]
3. The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1.
Yang Q; Chen X; Zhang Y; Hu S; Hu F; Huang Y; Ma T; Hu H; Tian H; Tian S; Ji YX; She ZG; Zhang P; Zhang XJ; Hu Y; Yang H; Yuan Y; Li H
Hepatology; 2021 Dec; 74(6):3018-3036. PubMed ID: 34272738
[TBL] [Abstract][Full Text] [Related]
4. A small-molecule inhibitor and degrader of the RNF5 ubiquitin ligase.
Ruan J; Liang D; Yan W; Zhong Y; Talley DC; Rai G; Tao D; LeClair CA; Simeonov A; Zhang Y; Chen F; Quinney NL; Boyles SE; Cholon DM; Gentzsch M; Henderson MJ; Xue F; Fang S
Mol Biol Cell; 2022 Nov; 33(13):ar120. PubMed ID: 36074076
[TBL] [Abstract][Full Text] [Related]
5. The E3 ligase RNF5 restricts SARS-CoV-2 replication by targeting its envelope protein for degradation.
Li Z; Hao P; Zhao Z; Gao W; Huan C; Li L; Chen X; Wang H; Jin N; Luo ZQ; Li C; Zhang W
Signal Transduct Target Ther; 2023 Feb; 8(1):53. PubMed ID: 36737599
[TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING.
Yang LL; Xiao WC; Li H; Hao ZY; Liu GZ; Zhang DH; Wu LM; Wang Z; Zhang YQ; Huang Z; Zhang YZ
Cell Death Dis; 2022 Oct; 13(10):889. PubMed ID: 36270989
[TBL] [Abstract][Full Text] [Related]
7. RNF185 is a novel E3 ligase of endoplasmic reticulum-associated degradation (ERAD) that targets cystic fibrosis transmembrane conductance regulator (CFTR).
El Khouri E; Le Pavec G; Toledano MB; Delaunay-Moisan A
J Biol Chem; 2013 Oct; 288(43):31177-91. PubMed ID: 24019521
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA.
Zhong B; Zhang L; Lei C; Li Y; Mao AP; Yang Y; Wang YY; Zhang XL; Shu HB
Immunity; 2009 Mar; 30(3):397-407. PubMed ID: 19285439
[TBL] [Abstract][Full Text] [Related]
9. E3 ubiquitin ligase ring finger protein 5 protects against hepatic ischemia reperfusion injury by mediating phosphoglycerate mutase family member 5 ubiquitination.
Ding MJ; Fang HR; Zhang JK; Shi JH; Yu X; Wen PH; Wang ZH; Cao SL; Zhang Y; Shi XY; Zhang HP; He YT; Yan B; Tang HW; Guo DF; Gao J; Liu Z; Zhang L; Zhang SJ; Zhang XJ; Guo WZ
Hepatology; 2022 Jul; 76(1):94-111. PubMed ID: 34735734
[TBL] [Abstract][Full Text] [Related]
10. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies.
Jeon YJ; Khelifa S; Ratnikov B; Scott DA; Feng Y; Parisi F; Ruller C; Lau E; Kim H; Brill LM; Jiang T; Rimm DL; Cardiff RD; Mills GB; Smith JW; Osterman AL; Kluger Y; Ronai ZA
Cancer Cell; 2015 Mar; 27(3):354-69. PubMed ID: 25759021
[TBL] [Abstract][Full Text] [Related]
12. Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability.
Roy SJ; Glazkova I; Fréchette L; Iorio-Morin C; Binda C; Pétrin D; Trieu P; Robitaille M; Angers S; Hébert TE; Parent JL
Mol Endocrinol; 2013 Aug; 27(8):1245-66. PubMed ID: 23798571
[TBL] [Abstract][Full Text] [Related]
13. Regulation of endoplasmic reticulum-associated degradation by RNF5-dependent ubiquitination of JNK-associated membrane protein (JAMP).
Tcherpakov M; Delaunay A; Toth J; Kadoya T; Petroski MD; Ronai ZA
J Biol Chem; 2009 May; 284(18):12099-109. PubMed ID: 19269966
[TBL] [Abstract][Full Text] [Related]
14. RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization.
Didier C; Broday L; Bhoumik A; Israeli S; Takahashi S; Nakayama K; Thomas SM; Turner CE; Henderson S; Sabe H; Ronai Z
Mol Cell Biol; 2003 Aug; 23(15):5331-45. PubMed ID: 12861019
[TBL] [Abstract][Full Text] [Related]
15. The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis.
Delaunay A; Bromberg KD; Hayashi Y; Mirabella M; Burch D; Kirkwood B; Serra C; Malicdan MC; Mizisin AP; Morosetti R; Broccolini A; Guo LT; Jones SN; Lira SA; Puri PL; Shelton GD; Ronai Z
PLoS One; 2008 Feb; 3(2):e1609. PubMed ID: 18270596
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5
Li Y; Tinoco R; Elmén L; Segota I; Xian Y; Fujita Y; Sahu A; Zarecki R; Marie K; Feng Y; Khateb A; Frederick DT; Ashkenazi SK; Kim H; Perez EG; Day CP; Segura Muñoz RS; Schmaltz R; Yooseph S; Tam MA; Zhang T; Avitan-Hersh E; Tzur L; Roizman S; Boyango I; Bar-Sela G; Orian A; Kaufman RJ; Bosenberg M; Goding CR; Baaten B; Levesque MP; Dummer R; Brown K; Merlino G; Ruppin E; Flaherty K; Ramer-Tait A; Long T; Peterson SN; Bradley LM; Ronai ZA
Nat Commun; 2019 Apr; 10(1):1492. PubMed ID: 30940817
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia.
Sondo E; Falchi F; Caci E; Ferrera L; Giacomini E; Pesce E; Tomati V; Mandrup Bertozzi S; Goldoni L; Armirotti A; Ravazzolo R; Cavalli A; Pedemonte N
Cell Chem Biol; 2018 Jul; 25(7):891-905.e8. PubMed ID: 29754957
[TBL] [Abstract][Full Text] [Related]
18. RING-finger protein 5 promotes hepatocellular carcinoma progression and predicts poor prognosis.
Zhang Y; Li J; Chen H; Zhang C; You S; Zhao Y; Lin X; Yu Y; Fang F; Fang T; Wang X
Hum Cell; 2021 Mar; 34(2):530-538. PubMed ID: 33469898
[TBL] [Abstract][Full Text] [Related]
19. Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis.
Fujita Y; Khateb A; Li Y; Tinoco R; Zhang T; Bar-Yoseph H; Tam MA; Chowers Y; Sabo E; Gerassy-Vainberg S; Starosvetsky E; James B; Brown K; Shen-Orr SS; Bradley LM; Tessier PA; Ronai ZA
Cell Rep; 2018 Sep; 24(12):3296-3311.e6. PubMed ID: 30232010
[TBL] [Abstract][Full Text] [Related]
20. Ring finger protein 5 activates sterol regulatory element-binding protein 2 (SREBP2) to promote cholesterol biosynthesis via inducing polyubiquitination of SREBP chaperone SCAP.
Kuan YC; Takahashi Y; Maruyama T; Shimizu M; Yamauchi Y; Sato R
J Biol Chem; 2020 Mar; 295(12):3918-3928. PubMed ID: 32054686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
